Erelzi and Pulmonary oedema - a phase IV clinical study of FDA data

Summary:

Pulmonary oedema is reported as a side effect among people who take Erelzi (etanercept-szzs), especially for people who are male, 40-49 old, have been taking the drug for 2 - 5 years also take Enbrel, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Pulmonary oedema when taking Erelzi. It is created by eHealthMe based on reports of 11,624 people who have side effects when taking Erelzi from the FDA, and is updated regularly.

What is Erelzi?

Erelzi has active ingredients of etanercept-szzs. eHealthMe is studying from 11,625 Erelzi users. Check the latest studies of Erelzi.

What is Pulmonary oedema?

Pulmonary oedema (fluid accumulation in the lungs) is found to be associated with 1,847 drugs and 1,967 conditions by eHealthMe. Check the latest studies of Pulmonary oedema.

On Aug, 01, 2026

11,624 people reported to have side effects when taking Erelzi.
Among them, 33 people (0.28%) have Pulmonary oedema.

Among these 33 people:

How long have people been on Erelzi when they have Pulmonary oedema? *

What is the gender of people who have Pulmonary oedema when taking Erelzi? *

female: 29.03 %
male: 70.97 %

What is the age of people who have Pulmonary oedema when taking Erelzi? *

What are other drugs people take besides Erelzi? *

What are other side effects people have besides Pulmonary oedema? *

Drug Ineffective: 16 people, 48.48%
Pneumonia: 10 people, 30.30%
Hepatic Enzyme Increased: 10 people, 30.30%
Generalised Oedema (swelling all over the body): 9 people, 27.27%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 9 people, 27.27%
Pleural Effusion (water on the lungs): 9 people, 27.27%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 9 people, 27.27%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 9 people, 27.27%
Encephalopathy (functioning of the brain is affected by some agent or condition): 9 people, 27.27%
Granuloma (a small area of inflammation due to tissue injury): 9 people, 27.27%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 21 people, 63.64%
Ankylosing Spondylitis (type of arthritis affecting the spine): 11 people, 33.33%
Psoriasis (immune-mediated disease that affects the skin): 9 people, 27.27%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 9 people, 27.27%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 9.09%
Pain: 1 person, 3.03%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Erelzi and have Pulmonary oedema?

- Check whether Pulmonary oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Erelzi:

Erelzi (11,625 reports)

Pulmonary oedema treatments and more:

Pulmonary oedema (53,624 reports)

Browse all side effects of Erelzi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary oedema:

Pulmonary oedema (1,847 drugs)

Browse all the conditions that are associated with Pulmonary oedema:

Pulmonary oedema (1,967 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etanercept-szzs (the active ingredients of Erelzi) and Erelzi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.